Format
Sort by
Items per page

Send to

Choose Destination

Best matches for lithium bipolar:

An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms. Won E et al. Int J Mol Sci. (2017)

Drug Interactions with Lithium: An Update. Finley PR et al. Clin Pharmacokinet. (2016)

Hypertensive bipolar: chronic lithium toxicity in patients taking ACE inhibitor. Masiran R et al. BMJ Case Rep. (2017)

Search results

Items: 1 to 20 of 8543

1.

Population Pharmacokinetics and Exposure-Response of Lithium Carbonate in Patients Based on Tubular Reabsorption Mechanisms.

Yamaguchi D, Tsuji Y, Sonoda M, Shin K, Kito H, Ogami C, Kasai H, To H, Kamimura H.

Eur J Drug Metab Pharmacokinet. 2018 Dec 7. doi: 10.1007/s13318-018-0536-0. [Epub ahead of print]

PMID:
30536114
2.

Combined actions of blueberry extract and lithium on neurochemical changes observed in an experimental model of mania: exploiting possible synergistic effects.

Spohr L, Soares MSP, Oliveira PS, da Silveira de Mattos B, Bona NP, Pedra NS, Teixeira FC, do Couto CAT, Chaves VC, Reginatto FH, Lisboa MT, Ribeiro AS, Lencina CL, Stefanello FM, Spanevello RM.

Metab Brain Dis. 2018 Dec 7. doi: 10.1007/s11011-018-0353-9. [Epub ahead of print]

PMID:
30535659
3.

An Interesting Case of Carbamazepine-Induced Stevens-Johnson Syndrome.

Masuka JT, Muzopambwa G, Khoza S, Chibanda D.

Drug Saf Case Rep. 2018 Dec 10;6(1):1. doi: 10.1007/s40800-018-0095-y.

PMID:
30535610
4.

Lithium-induced Thyroiditis in a Patient Having Bipolar Affective Disorder - A Rare Case Report.

Arathil P, Mathew K, Narayanan D.

Indian J Psychol Med. 2018 Nov-Dec;40(6):577-579. doi: 10.4103/IJPSYM.IJPSYM_403_17.

PMID:
30533956
5.

The Emergent Course of Bipolar Disorder: Observations Over Two Decades From the Canadian High-Risk Offspring Cohort.

Duffy A, Goodday S, Keown-Stoneman C, Grof P.

Am J Psychiatry. 2018 Dec 11:appiajp201818040461. doi: 10.1176/appi.ajp.2018.18040461. [Epub ahead of print]

PMID:
30525908
6.

Identification of potential genetic risk factors for bipolar disorder by whole-exome sequencing.

Husson T, Duboc JB, Quenez O, Charbonnier C, Rotharmel M, Cuenca M, Jegouzo X, Richard AC, Frebourg T, Deleuze JF, Boland A, Genin E, Debette S, Tzourio C, Campion D, Nicolas G, Guillin O; FREX Consortium.

Transl Psychiatry. 2018 Dec 5;8(1):268. doi: 10.1038/s41398-018-0291-7.

7.

Bottom-up gamma and bipolar disorder, clinical and neuroepigenetic implications.

Garcia-Rill E, D'Onofrio S, Mahaffey S, Bisagno V, Urbano FJ.

Bipolar Disord. 2018 Dec 1. doi: 10.1111/bdi.12735. [Epub ahead of print] Review.

PMID:
30506611
8.

Lithium during pregnancy and after delivery: a review.

Poels EMP, Bijma HH, Galbally M, Bergink V.

Int J Bipolar Disord. 2018 Dec 2;6(1):26. doi: 10.1186/s40345-018-0135-7. Review.

PMID:
30506447
9.

Psychopharmacological prescribing practices in pregnancy for women with severe mental illness: A multicentre study.

Galbally M, Frayne J, Watson SJ, Snellen M.

Eur Neuropsychopharmacol. 2018 Nov 26. pii: S0924-977X(18)31964-3. doi: 10.1016/j.euroneuro.2018.11.1103. [Epub ahead of print]

PMID:
30497841
10.

Chronotype and cellular circadian rhythms predict the clinical response to lithium maintenance treatment in patients with bipolar disorder.

McCarthy MJ, Wei H, Nievergelt CM, Stautland A, Maihofer AX, Welsh DK, Shilling P, Alda M, Alliey-Rodriguez N, Anand A, Andreasson OA, Balaraman Y, Berrettini WH, Bertram H, Brennand KJ, Calabrese JR, Calkin CV, Claasen A, Conroy C, Coryell WH, Craig DW, D'Arcangelo N, Demodena A, Djurovic S, Feeder S, Fisher C, Frazier N, Frye MA, Gage FH, Gao K, Garnham J, Gershon ES, Glazer K, Goes F, Goto T, Harrington G, Jakobsen P, Kamali M, Karberg E, Kelly M, Leckband SG, Lohoff F, McInnis MG, Mondimore F, Morken G, Nurnberger JI, Obral S, Oedegaard KJ, Ortiz A, Ritchey M, Ryan K, Schinagle M, Schoeyen H, Schwebel C, Shaw M, Shekhtman T, Slaney C, Stapp E, Szelinger S, Tarwater B, Zandi PP, Kelsoe JR.

Neuropsychopharmacology. 2018 Nov 16. doi: 10.1038/s41386-018-0273-8. [Epub ahead of print]

PMID:
30487653
11.

A chemical genetic screen reveals a role for proteostasis in capsule and biofilm formation by Cryptococcus neoformans.

Mayer FL, Sánchez-León E, Kronstad JW.

Microb Cell. 2018 Oct 31;5(11):495-510. doi: 10.15698/mic2018.11.656.

12.

Compliance with the guidelines for laboratory monitoring of patients treated with lithium: a retrospective follow-up study among ambulatory patients in the Netherlands.

Nederlof M, Egberts TCG, van Londen L, de Rotte MCFJ, Souverein PC, Herings RCM, Heerdink ER.

Bipolar Disord. 2018 Nov 25. doi: 10.1111/bdi.12730. [Epub ahead of print]

PMID:
30472760
13.

Lithium improved behavioral and epileptic symptoms in an adolescent with ring chromosome 20 and bipolar disorder not otherwise specified.

Inal A, Chaumette B, Soleimani M, Guerrot AM, Goldenberg A, Lebas A, Gerardin P, Ferrafiat V.

Clin Case Rep. 2018 Oct 12;6(11):2234-2239. doi: 10.1002/ccr3.1796. eCollection 2018 Nov.

14.

[The relationship between intake of lithium and neuroradiological alterations in bipolar disorder. Are there predictors of clinical remission?]

Hamm C, Queissner R, Pilz R, Birner A, Platzer M, Fellendorf F, Maget A, Bengesser S, Dalkner N, Reininghaus B, Reininghaus E.

Fortschr Neurol Psychiatr. 2018 Nov 19. doi: 10.1055/a-0637-1820. [Epub ahead of print] German.

PMID:
30453335
15.

Lithium Toxicity with Severe Bradycardia Post Sleeve Gastrectomy: a Case Report and Review of the Literature.

Dahan A, Porat D, Azran C, Mualem Y, Sakran N, Abu-Abeid S.

Obes Surg. 2018 Nov 17. doi: 10.1007/s11695-018-3597-x. [Epub ahead of print]

PMID:
30448980
16.

Lithium treatment in bipolar adolescents: a follow-up naturalistic study.

Masi G, Milone A, Scrinzi G, Mucci M, Viglione V, Bruni G, Berloffa S, Pisano S.

Neuropsychiatr Dis Treat. 2018 Oct 17;14:2749-2753. doi: 10.2147/NDT.S172654. eCollection 2018.

17.

Illness and drug modifiable factors associated with violent behavior in homeless people with severe mental illness: results from the French Housing First (FHF) program.

Fond G, Boyer L, Boucekine M, Girard V, Loubière S, Lenoir C, Auquier P, Tinland A; French Housing First Study Group.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Nov 10;90:92-96. doi: 10.1016/j.pnpbp.2018.11.006. [Epub ahead of print]

PMID:
30423419
18.

Lithium Monotherapy Associated Longitudinal Effects on Resting State Brain Networks in Clinical Treatment of Bipolar Disorder.

Spielberg JM, Matyi MA, Karne H, Anand A.

Bipolar Disord. 2018 Nov 12. doi: 10.1111/bdi.12718. [Epub ahead of print]

PMID:
30421491
19.

[Update - Lithium in the Long-Term Treatment of Bipolar Disorders].

Petzold J, Bauer M, Severus E.

Fortschr Neurol Psychiatr. 2018 Nov 12. doi: 10.1055/a-0633-2511. [Epub ahead of print] German.

PMID:
30419584
20.

Contribution of NHE3 and dietary phosphate to lithium pharmacokinetics.

Thomas L, Xue J, Dominguez Rieg JA, Rieg T.

Eur J Pharm Sci. 2018 Nov 9;128:1-7. doi: 10.1016/j.ejps.2018.11.008. [Epub ahead of print]

PMID:
30419292

Supplemental Content

Loading ...
Support Center